This compound is a pharmaceutical intermediate featured in PubChem as this compound, with a molecular weight of 473. 13 and a logP of 3.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
N1,N2-Bis(4-((3-chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)oxalamide
pharmaceutical intermediate
Afatinib Impurity AFT-8
pharmaceutical raw material
(R)-N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((R)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-4-(dimethylamino)-3-hydroxybutanamide
pharmaceutical intermediate
N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(((S)-tetrahydrofuran-3-yl)oxy)quinazolin-6-yl)-3,4-bis(dimethylamino)butanamide
pharmaceutical intermediate
(S)-4-Methyloxazolidine-2,5-dione
pharmaceutical intermediate
1-(4-chlorophenyl)-3-oxoisoindoline
pharmaceutical intermediate
4-(4-chlorophenyl)-1H-2,3-benzoxazin-1-one
pharmaceutical intermediate
2-Hydroxy-3-trifluoromethylpyridine
pharmaceutical intermediate
N-[4-(3-chloro-4-fluoroanilino)-7-[(3S)-oxolan-3-yl]oxyquinazolin-6-yl]-N',N'-dimethyloxamide
TXTARPMHKVXFGC-ZDUSSCGKSA-N
CN(C)C(=O)C(=O)NC1=C(C=C2C(=C1)C(=NC=N2)NC3=CC(=C(C=C3)F)Cl)O[C@H]4CCOC4
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.